Founded in 1989, Natus is creating a platform of screening technologies that can be easily used by medical and non-medical personnel in hospital nurseries, providing for early detection of medical conditions such as hearing impairment. An ALGO newborn hearing screen can be completed in under five minutes and may be performed within hours of birth. More than 2000 ALGO units have been sold to hospitals and clinics in the U.S. and overseas. Natus also assists clinicians in the management of neonatal jaundice. Nearly two thirds of all newborns develop some degree of jaundice within the first days of life.
Neonatal jaundice is the single largest cause for hospital re-admission in newborns.
Five to six percent of newborns will develop a more serious condition called hyperbilirubinemia. End Tidal Breath Analyzer non-invasively detects the presence of hemolysis in neonates, assisting in rapid identification of those at risk for hyperbilirubinemia or other hemolytic disease.